Profile

ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics to address significant unmet need in oncology, immuno-oncology and immunology. ImmunoBiochem innovates in the areas of new target discovery and emerging payload modalities leveraging AI/ML and proteomic tools to uncover new biology and develop novel chemistries. ImmunoBiochem’s latest innovation are novel bioconjugates for precision immunology that utilize unique antibody targets for delivery of potent protein degrader payloads targeting select immunological pathways in specific cell subtypes in the correct context in relevant autoimmune disorders. ImmunoBiochem is a revenue-generating biotech and has several pharma and academic partnerships.

ImmunoBiochem Corporation logo

Website

immunobiochem.com

Contact


Event details

Date: November 4 - 6, 2024

Event contact

Rita Patlan
Area Director
Europe: Aerospace and Defence, Environmental Technologies and Infrastructure

Participants

12 in total